Steven Boyd
Board Member
Avalo Therapeutics, Inc. (AVTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steven Boyd
Steven Boyd is recorded as Board Member at Avalo Therapeutics, Inc. (AVTX). Avalo Therapeutics, Inc. reported in an 8-K filed August 11, 2022 that Steven Boyd resigned as the Board, effective August 8, 2022.
“On August 8, 2022, Steven Boyd and Keith Maher, MD, both of Armistice Capital, LLC, the investment manager to Armistice Capital Master Fund Ltd. (the "Master Fund"), notified the Board of Directors (the "Board") of Avalo Therapeutics, Inc. (the "Company") that they have resigned from their positions on the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-06-18–present
-
2017-01-01–2022-08-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Avalo Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Garry A. Neil CEO
- Garry Neil CEO, Board Member
- Michael Cola CEO, Chairman, Board Member
- Michael F. Cola CEO, Board Member
- Peter Greenleaf CEO
- Michael Heffernan Chairman, Board Member
- Sol Barer Chairman, Board Member
- Sol J. Barer Chairman, Board Member
- Chris Sullivan CFO
- Christopher Sullivan CFO, Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.